loadpatents
name:-0.030461072921753
name:-0.0093240737915039
name:-0.059060096740723
Wooddell; Christine I Patent Filings

Wooddell; Christine I

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wooddell; Christine I.The latest application filed is for "alpha-1 antitrypsin (aat) rnai agents, compositions including aat rnai agents, and methods of use".

Company Profile
9.7.17
  • Wooddell; Christine I - Madison WI
  • Wooddell; Christine I. - Madison WI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
Grant 11,384,355 - Wooddell , et al. July 12, 2
2022-07-12
Alpha-1 Antitrypsin (aat) Rnai Agents, Compositions Including Aat Rnai Agents, And Methods Of Use
App 20220170015 - Li; Zhen ;   et al.
2022-06-02
Rnai Agents For Hepatitis B Virus Infection
App 20220079973 - LI; Zhen ;   et al.
2022-03-17
Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
Grant 11,203,756 - Li , et al. December 21, 2
2021-12-21
Rnai Agents For Hepatitis B Virus Infection
App 20210100829 - LI; Zhen ;   et al.
2021-04-08
Rnai Therapy For Hepatitis B Virus Infection
App 20210052624 - WOODDELL; Christine I. ;   et al.
2021-02-25
RNAi therapy for hepatitis B virus infection
Grant 10,806,750 - Wooddell , et al. October 20, 2
2020-10-20
Alpha-1 AntiTrypsin (AAT) RNAi Agents, Compositions Including AAT RNAi Agents, And Methods of Use
App 20200208149 - Li; Zhen ;   et al.
2020-07-02
Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
Grant 10,450,565 - Li , et al. Oc
2019-10-22
Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin
App 20190284558 - Wooddell; Christine I ;   et al.
2019-09-19
RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION
App 20190255091 - Li; Zhen ;   et al.
2019-08-22
Methods Of Treatment For Alpha-1 Antitrypsin Deficiency
App 20190071670 - Wooddell; Christine I. ;   et al.
2019-03-07
RNAi Therapy for Hepatitis B Virus Infection
App 20190022123 - Wooddell; Christine I. ;   et al.
2019-01-24
RNAi Therapy for Hepatitis B Virus Infection
Grant 10,130,651 - Wooddell , et al. November 20, 2
2018-11-20
Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin
App 20180258430 - Wooddell; Christine I. ;   et al.
2018-09-13
Alpha-1 AntiTrypsin (AAT) RNAi Agents, Compositions Including AAT RNAi Agents, And Methods of Use
App 20180195069 - Li; Zhen ;   et al.
2018-07-12
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
Grant 10,006,025 - Wooddell , et al. June 26, 2
2018-06-26
Peptide-Based In Vivo siRNA Delivery System
App 20170056472 - Rozema; David B. ;   et al.
2017-03-02
RNAi Therapy for Hepatitis B Virus Infection
App 20170035796 - Wooddell; Christine I. ;   et al.
2017-02-09
Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin
App 20150361427 - Wooddell; Christine I ;   et al.
2015-12-17
Methods for expression of transgenes
Grant 8,021,875 - Wooddell , et al. September 20, 2
2011-09-20
Methods for expression of transgenes
App 20100120152 - Wooddell; Christine I. ;   et al.
2010-05-13
DNA cassette for cellular expression of small RNA
App 20050196862 - Wooddell, Christine I. ;   et al.
2005-09-08
Nucleic acid expression from linear nucleic acids
App 20020061861 - Herweijer, Hans ;   et al.
2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed